English | Deutsch
  • About Us
    • From the laboratory into the world
    • Research & Development
    • Quality Management
    • News / Press
    • Career
  • Products
    • Human Milk Oligosaccharides
  • Applications
    • Nutrition / Food Ingredients
    • Products for Research & Development
  • Contact
    • Public Relations contact
    • Location
  • General terms & conditions
English | Deutsch
  • About Us
    • From the laboratory into the world
    • Research & Development
    • Quality Management
    • News / Press
    • Career
  • Products
    • Human Milk Oligosaccharides
      • 2'-Fucosyllactose (2'-FL)
      • Lacto-N-neotetraose (LNnT)
      • Lacto-N-tetraose (LNT)
      • 3-Fucosyllactose (3-FL)
      • Difucosyllactose (DiFL)
      • Lacto-N-triose II (LNT-II)
      • Lacto-N-fucopentaose I
        (LNFP I)
      • Lacto-N-fucopentaose III
        (LNFP III)
      • Lacto-N-fucopentaose V
        (LNFP V)
      • 6´-Sialyllactose (6´-SL)
      • 3´-Sialyllactose (3´-SL)
      • 5HMO-Mix
      • Other Human Milk Oligosaccharides
      • Scientific References
  • Applications
    • Nutrition / Food Ingredients
      • Infant Nutrition
      • General Nutrition / Therapeutic Nutrition
      • Scientific References
    • Products for Research & Development
  • Contact
    • Public Relations contact
    • Location
  • General terms & conditions

News and Press Announcements

  • From the laboratory into the world
  • Research & Development
  • Quality Management
  • News / Press
  • Career

Archive

  • 2020
  • 2019

News and Press Releases

2020

23.09.2020 PR

Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market: Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen…
read more

27.05.2020 PR

Jennewein publishes new results on the norovirus-inhibiting effect of complex oligosaccharides: Jennewein Biotechnologie GmbH today announces the publication of the latest…
read more

20.05.2020 PR

Supply of Key Ingredient in advanced infant formula by Jennewein is secured: Jennewein Biotechnologie GmbH, a worldwide leading manufacturer of human milk…
read more

09.01.2020

Publication of a toxicological study: a milestone for Jennewein Biotechnologie for the GRAS approval of the HMO-Mix: Jennewein Biotechnology announces another milestone in the Worldwide approval of…
read more

2019

25.11.2019

Jennewein Biotechnologie obtains US-FDA GRAS status on alternative 2’-fucosyllactose fermentation strain.: Nov. 25th. 2019, Jennewein Biotechnologie GmbH, Rheinbreitbach, the leading manufacturer…
read more

  • Home
  • Imprint
  • Privacy Policy
  • Sitemap
  • Contact
  • General terms & conditions

© Jennewein Biotechnologie GmbH 2021